2009 Worldwide Diagnostics Market Research Bundle

Three in One Report Bundle! (Plus a bonus market alert.) Combined these reports would be over $8,490 (single user license). As a bundle, these reports are available for over 25% off cover price - a special price of $5,995.
What does the diagnostic market look like today, how is the continuing economic news effecting the market, and what are companies doing right now to prosper? This diagnostic industry market research bundle, with over 1,200 pages, seeks to answer these questions and provide market watchers with the most comprehensive view of the industry. The purpose of the Kalorama Bundles is to allow companies to stretch their market research budget by providing multiple related reports, each available for sale on their own, together in one offering at a significant value.

Three of Kalorama's Diagnostic Market Research Reports, in One Affordable Bundle

This Worldwide Diagnostics Market Research Bundle represents three of our most innovative and best-selling topics related to the Diagnostic Industry today. The Bundle consists of one joined PDF containing the complete edition of each of these titles. Each of these titles is intact with their own table of contents:

In Vitro Diagnostics in a Recessionary Economy: IVD Market Forecasts, Analysis and Success Strategies

This title looks at the 2009 in vitro diagnostic market and answers the question - is IVD a recession-proof market? Many experts contend that it is, but that doesn't mean there aren't danger signs that marketers will have to watch out for. Kalorama Diagnostic analyst Shara Rosen updates IVD top level category markets for 2009 and forecasts for future revenues, and provide strategic recommendations for companies operating in this economy.

The Worldwide Market for In Vitro Diagnostic Tests, 6th Edition
Complete Coverage of Immunoassays, Core Lab Tests, Molecular DX, Point of Care, Blood Banking, Hematology, Microbiology and Virology and More...

Used by the top diagnostic companies for their business planning, Shara Rosen’s report offers a great value by covering every segment of in vitro diagnostics with reliable forecasts, unprecedented company coverage and expert analysis. Published in May 2008 with a preface for the current economy written December 2008 the report covers every area of in vitro diagnostics - point of care, hematology, core lab, microbiology and virology, cytology and histology, blood banking, molecular diagnostics and more. The report details trends including intense consolidation and molecular testing that are shaping this industry. There are over 900 pages in this report.

What is Working in In Vitro Diagnostics Strategic Advice From Kalorama's Top Diagnostic Industry Analyst

Kalorama Information has been watching diagnostic markets for some time, and we have observed companies succeed and fail over time. With this report, you can benefit from that analysis as applied to the commercialization of diagnostic products. In this strategic report, analyst Shara Rosen consolidates her years of experience watching the in vitro diagnostic market and looks at what has tend to work and what does not. In the course of describing successful commercialization strategies, Rosen provides plenty of real-world examples.

AND an Added Bonus:

Kalorama's Swine Flu Market Alert, written in May of 2009, describes the mechanisms of the virus that has focused media and public health attention on several areas of the diagnostic industry. The report and forecasts possibilities for the impact of the continued H1N1 virus threat on diagnostic industry business plans. Expand The Value of This Useful Resource With a Departmental License - Will 1 to 10 employees in the same company be using this title? Upgrade to a departmental license for just 20% more ($7,190)

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/23/2009 - 3